Emmenegger, Marc https://orcid.org/0000-0002-6073-8811
De Cecco, Elena https://orcid.org/0000-0002-0148-2596
Hruska‐Plochan, Marian https://orcid.org/0000-0002-9253-4362
Eninger, Timo
Schneider, Matthias M https://orcid.org/0000-0002-1894-1859
Barth, Melanie
Tantardini, Elena https://orcid.org/0000-0001-9189-3390
de Rossi, Pierre
Bacioglu, Mehtap https://orcid.org/0000-0003-0304-7026
Langston, Rebekah G
Kaganovich, Alice
Bengoa‐Vergniory, Nora https://orcid.org/0000-0002-3700-0464
Gonzalez‐Guerra, Andrès
Avar, Merve https://orcid.org/0000-0003-4665-5558
Heinzer, Daniel https://orcid.org/0000-0002-3282-4042
Reimann, Regina
Häsler, Lisa M
Herling, Therese W
Matharu, Naunehal S
Landeck, Natalie https://orcid.org/0000-0002-8399-4009
Luk, Kelvin https://orcid.org/0000-0002-6591-6269
Melki, Ronald https://orcid.org/0000-0003-0000-7096
Kahle, Philipp J
Hornemann, Simone https://orcid.org/0000-0002-2674-9891
Knowles, Tuomas P J
Cookson, Mark R https://orcid.org/0000-0002-1058-3831
Polymenidou, Magdalini
Jucker, Mathias https://orcid.org/0000-0001-9045-1072
Aguzzi, Adriano https://orcid.org/0000-0002-0344-6708
Funding for this research was provided by:
University of Zurich and University Hospital of Zurich
Swiss Personalized Health Network (2017DRI17)
NOMIS Stiftung
European Research Council (ERC Prion2020)
European Research Council (670958)
EU Horizon 2020 (ETN grant 674979‐Nanotrans)
National Centre for Competence in Research (51NF40‐182880)
Swiss National Science Foundation Project Grant (310030_192650)
EU/EFPIA/Innovative Medicines Initiative 2 Joint Undertaking (116060)
Forschungskredit University of Zurich
Article History
Received: 18 June 2021
Revised: 5 July 2021
Accepted: 6 July 2021
First Online: 26 July 2021
Conflict of interest
: AA is a member of the board of directors of Mabylon AG which has funded antibody‐related work in the Aguzzi lab in the past. All other authors declare no competing interests.